Takara Bio USA Partners with SPT Labtech to Deliver Automation-Ready NGS Library Preparation Technologies
Trusted NGS chemistries from Takara Bio now optimized for firefly® [...]
ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics
Cambridge, UK, 20 October 2026: ScionxBio (the “company”, operating as [...]
Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands
Celea has now contracted Qureight as the end-to-end imaging CRO [...]
Leading Life Science Organisations Collaborate for Second London Bio-Innovation Week
One Nucleus, SLAS, and ELRIG will connect their communities through [...]
Undecimal Bio launches with $18 million oversubscribed Seed financing to address ‘liver trap’ in siRNA therapeutic delivery
A spin-out focused on AI-enabled decoding of the deliverome Proprietary [...]
Mursla Bio Publishes Peer-Reviewed Validation of Tissue-Specific Extracellular Vesicle Platform for Liquid Biopsy
Study published in Journal of Extracellular Vesicles validates platform for [...]
Google DeepMind’s Nature Study on Watermarking AI-Designed Proteins Validated with Carterra HT-SPR
New paper published in Nature shows watermarks can be embedded [...]
Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia
AMX-883, Amphista’s first asset to enter the clinic, is a [...]
Carterra advances lab-in-the-loop drug discovery through new scientific collaboration
Bringing together scientific and technical expertise to advance development of [...]
Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
o2h co-discovery to host second edition of the Cambridge x [...]